[SRNE] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
12-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -87.83%
YoY- -402.33%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 902 1,173 775 142 217 74 56 58.84%
PBT -46,113 -10,975 -8,454 -4,737 -943 -1,088 -576 107.46%
Tax -1,164 -17 5 2 4 3 2 -
NP -44,949 -10,958 -8,454 -4,737 -943 -1,088 -576 106.58%
Tax Rate - - - - - - - -
Total Cost 45,851 12,131 9,229 4,878 1,160 1,162 632 104.09%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -4,983.26 -934.19 -1,090.84 -3,345.11 -434.35 -1,466.69 -1,019.37 30.24%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -0.97 -0.30 -0.33 -0.35 -0.08 -0.11 -0.07 54.91%
EPS Diluted -0.97 -0.30 -0.33 -0.35 -0.08 -0.11 -0.07 54.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.